Blacksmith Medicines Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
M&A
- (Cancelled)
- Investors
-
4
Blacksmith Medicines General Information
Description
Developer of metalloenzyme chemistry platform designed to develop medicines for immuno-oncology and inflammatory diseases. The company's platform uses metalloenzyme-targeted medicines that combine a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzyme's active site, enabling medical professionals to rapidly build potent and selective inhibitors in a stepwise and predictable manner.
Contact Information
Website
www.blacksmithmedicines.comCorporate Office
- 3033 Science Park Road
- Suite 270
- San Diego, CA 92121
- United States
Corporate Office
- 3033 Science Park Road
- Suite 270
- San Diego, CA 92121
- United States
Blacksmith Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 02-Jan-2023 | Cancelled | Generating Revenue | |||
| 1. Seed Round | 15-Nov-2019 | 00000 | 00000 | 00000 | Completed | Clinical Trials - Phase 1 |
Blacksmith Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
Blacksmith Medicines Comparisons
Industry
Financing
Details
000000
000000
Blacksmith Medicines Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| NexImmune | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | 00 | 00000 | 000000000 | 00000 |
Blacksmith Medicines Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Blacksmith Medicines Patents
Blacksmith Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3233328-A1 | Lpxc inhibitors and uses thereof | Pending | 28-Sep-2021 | 00000000000 | |
| AU-2022357226-A1 | Lpxc inhibitors and uses thereof | Pending | 28-Sep-2021 | 00000000000 | |
| EP-4408853-A1 | Lpxc inhibitors and uses thereof | Pending | 28-Sep-2021 | 00000000000 | |
| US-20240270773-A1 | Lpxc inhibitors and uses thereof | Pending | 28-Sep-2021 | 00000000000 | 0 |
| EP-4291550-A1 | Antibacterial compounds | Pending | 11-Feb-2021 | A61P31/04 |
Blacksmith Medicines Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Zachary Zimmerman Ph.D | Co-Founder, Chief Executive Officer and Board Member | |
| David Puerta Ph.D | Co-Founder, Chief Operating Officer & Vice President of Discovery | |
| Zac Rhodes | Controller | |
| Seth Cohen Ph.D | Scientific Co-Founder |
Blacksmith Medicines Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Dorsey | MagnaSci Ventures | Board Member | 000 0000 |
| John Schmid | Self | Board Member | 000 0000 |
| Mario Polywka Ph.D | Evotec | Board Member | 000 0000 |
| Stephen Worland Ph.D | Self | Board Member | 000 0000 |
| Zachary Zimmerman Ph.D | Blacksmith Medicines | Co-Founder, Chief Executive Officer and Board Member | 000 0000 |
Blacksmith Medicines Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Blacksmith Medicines Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | 000 0000 | 000000 0 |
| Evotec | Corporation | Minority | 000 0000 | 000000 0 |
| MagnaSci Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
| MP Healthcare Venture Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Blacksmith Medicines Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Forge Therapeutics | 02-Jan-2023 | 0000000000 | Drug Discovery | 0000000 0 |
Blacksmith Medicines FAQs
-
When was Blacksmith Medicines founded?
Blacksmith Medicines was founded in 2017.
-
Who is the founder of Blacksmith Medicines?
Zachary Zimmerman Ph.D, David Puerta Ph.D, and Seth Cohen Ph.D are the founders of Blacksmith Medicines.
-
Who is the CEO of Blacksmith Medicines?
Zachary Zimmerman Ph.D is the CEO of Blacksmith Medicines.
-
Where is Blacksmith Medicines headquartered?
Blacksmith Medicines is headquartered in San Diego, CA.
-
What is the size of Blacksmith Medicines?
Blacksmith Medicines has 11 total employees.
-
What industry is Blacksmith Medicines in?
Blacksmith Medicines’s primary industry is Biotechnology.
-
Is Blacksmith Medicines a private or public company?
Blacksmith Medicines is a Private company.
-
What is Blacksmith Medicines’s current revenue?
The current revenue for Blacksmith Medicines is 000000.
-
How much funding has Blacksmith Medicines raised over time?
Blacksmith Medicines has raised $350K.
-
Who are Blacksmith Medicines’s investors?
Alexandria Venture Investments, Evotec, MagnaSci Ventures, and MP Healthcare Venture Management have invested in Blacksmith Medicines.
-
Who are Blacksmith Medicines’s competitors?
CytomX Therapeutics, NexImmune, and Aclaris Therapeutics are competitors of Blacksmith Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
